Skip to main content
Erschienen in: BMC Psychiatry 1/2023

Open Access 01.12.2023 | Research

Association of serum oleic acid level with depression in American adults: a cross-sectional study

verfasst von: Jiahui Yin, Siyuan Li, Jinling Li, Rongpeng Gong, Zhixia Jia, Junjun Liu, Zhi Jin, Jiguo Yang, Yuanxiang Liu

Erschienen in: BMC Psychiatry | Ausgabe 1/2023

Abstract

Background

As the most abundant fatty acid in plasma, oleic acid has been found to be associated with multiple neurological diseases; however, results from studies of the relationship between oleic acid and depression are inconsistent.

Methods

This cross-sectional study analyzed 4,459 adults from the National Health and Nutrition Examination Survey 2011–2014. The following covariates were adjusted in multivariable logistic regression models: age, sex, race/ethnicity, education level, marital status, body mass index, physical activity, smoking status, alcohol status, metabolic syndrome, omega-3 polyunsaturated fatty acids, and total cholesterol.

Results

Serum oleic acid levels were positively associated with depression. After adjusting for all covariates, for every 1 mmol/L increase in oleic acid levels, the prevalence of depression increased by 40% (unadjusted OR: 1.35, 95%CI: 1.16–1.57; adjusted OR: 1.40, 95% CI: 1.03–1.90).

Conclusions

Our study suggests that oleic acid may play a role in depression. Further research is needed to investigate the potential benefits of changing oleic acid levels for the treatment and prevention of depression.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12888-023-05271-0.
Jiahui Yin, Siyuan Li, Jinling Li, Rongpeng Gong and Zhixia Jia contributed equally to this work.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
FA
Fatty acid
MUFA
Monounsaturated fatty acid
MDD
Major depressive disorder
NHANES
National Health and Nutrition Examination Survey
CDC
Centers for Disease Control and Prevention
PHQ-9
Patient Health Questionnaire-9
BMI
Body mass index
SCD
Stearoyl-CoA desaturase
MetS
Metabolic syndrome

Introduction

Depression is a common psychological symptom associated with clinical depressive disorders such as major depressive disorder (MDD). More than 300 million people worldwide live with MDD, of whom 15% (48.16 million) are in the Americas [1]. During the coronavirus disease-19 pandemic, depression levels have risen dramatically [2, 3]. Depression is associated with various physical diseases and higher mortality, adversely affecting patients’ quality of life [4]. Therefore, effective preventive techniques and modifiable risk factors for depression should be investigated.
Fatty acids (FAs) are important compounds involved in various physiological processes, such as cell and tissue metabolism, function, and responsiveness to hormonal and other signals [5]. Several studies have demonstrated that FAs alter neurotransmission, cell survival, and neuroinflammation, which may play a role in neurological diseases [6]. Recent research has mostly focused on polyunsaturated fatty acids (PUFAs), whereas few studies have examined the relationship between plasma omega-9 monounsaturated fatty acids (MUFAs) and depression. Oleic acid, the most abundant FA in plasma, accounts for approximately 80% of plasma phospholipid MUFAs [7].
Previous studies have shown changes in oleic acid levels in patients with MDD; however, the results have been inconsistent. Ding et al. And Zhou et al. observed a decrease in oleic acid levels in patients with MDD [8, 9]. However, McNamara et al. found no significant differences in oleic acid levels between patients with MDD and healthy controls in the superior temporal gyrus [10]. Interestingly, in a case–control study of recurrent MDD, plasma oleic acid levels were significantly higher in patients with recurrent MDD than in the healthy controls [11].
Oleic acid intake has also been linked to anxiety and depression in women [12, 13]. In addition, the rate-limiting enzyme of oleic acid, stearoyl-CoA desaturase (SCD), has been found to cause neurotoxicity by producing MUFA and impairing microglia and macrophages [14]; it also plays a role in the pathogenesis of various diseases, such as obesity, Parkinson’s disease, and Alzheimer’s disease [1517]. However, few studies have explored the relationship between circulating oleic acid levels and depression, and the role of oleic acid in depression remains unknown.
Therefore, we aimed to explore the relationship between serum oleic acid levels and depression in a multi-ethnic community from the National Health and Nutrition Examination Survey (NHANES).

Methods

Study population

The participants in this study were recruited from the NHANES, a major program conducted by the Centers for Disease Control and Prevention (CDC) to assess the health and nutritional status of adults and children in the United States of America. The NHANES comprises demographic, socioeconomic, health-related, and medical information. NHANES survey is approved by the research ethics review board of the Centers for Disease Control and Prevention [18]. All participants provided informed consent. The NHANES data are publicly available. There was no additional authorization or ethical review required for the release of NHANES data for this study. Further information regarding the NHANES is available on the CDC website [19].
Participants in our study were screened on the basis of the following inclusion criteria: 1) age 18 years or older, 2) participation in serum fatty acid testing and availability of fasting laboratory specimens. The exclusion criteria were as follows: 1) incomplete Patient Health Questionnaire-9 (PHQ-9) (n = 452) and 2) missing information on oleic acid level (n = 46).

Measurement of serum oleic acid levels

Esterified fatty acids are hydrolyzed primarily from triglycerides, phospholipids and cholesteryl esters using sequential treatment with mineral acid and base in the presence of heat. Using a modification of [20], total fatty acids are hexane-extracted from the matrix (100uL serum) along with an internal standard solution containing stable isotopically-labeled fatty acids to account for recovery. The extract is derivatized with pentafluorobenzyl bromide (PFBBr) in the presence of triethylamine to form pentafluorobenzyl esters. The reaction mixture is injected onto a capillary gas chromatograph column to resolve oleic acid from other matrix constituents. Oleic acid is detected using electron capture negative-ion mass spectrometry. Oleic acid is measured using selected ion monitoring. Quantitation is accomplished by comparing the peak area of the analyte in the unknown with the peak area of a known amount in a calibrator solution. Calculations are corrected based on the peak area of the internal standard in the unknown compared with the peak area of the internal standard in the calibrator solution. Serum samples were processed, stored, and shipped to the Division of Laboratory Sciences, National Center for Environmental Health, CDC, Atlanta, GA, for testing. More information regarding laboratory techniques and quality assurance has been previously documented [21].

Assessment of depression

The 9-item PHQ-9 was used to assess depression. The PHQ-9 is well accepted as an accurate and reliable technique for depression screening [2224]. The PHQ-9 contains nine items regarding the frequency of depressive symptoms [25]. Each question is scored from “0” (not at all) to “3” (nearly every day). The total PHQ-9 score can vary from 0 to 27, and a score of ≥ 10 was defined as depression in this study. Based on the cutoff point, the PHQ-9 achieved a sensitivity of 85% and a specificity of 89% for detecting MDD [26].

Covariates

Model covariates were selected based on a priori knowledge [11, 27]. Self-reported sociodemographic characteristics included age, sex (male/female), race/ethnicity (non-Hispanic white, Mexican American, non-Hispanic black, other Hispanic, or other race/multiple races), education level (< high school/completed high school or > high school), and marital status (married/living with partner or never married/widowed/divorced/separated).
Physical activity was assessed by vigorous physical activity (high-intensity activities and fitness and sports such as running or basketball) and moderate physical activity (e.g., brisk walking, swimming, and bicycling at a regular pace) reported by participants. Alcohol status and smoking status were used as categorical variables. Body mass index (BMI) was measured as weight (kg) divided by height (m) squared. Alcohol status was determined by answers to the question, “Have you had at least 12 alcohol drinks a year?” (yes/no). Participants were divided into never smokers (smoked < 100 cigarettes), former smokers (currently not smoking but smoked ≥ 100 cigarettes), and current smokers (≥ 100 cigarettes and currently smoking every day or some days).
Metabolic syndrome (MetS) was defined according to the updated National Cholesterol Education Program/Adult Treatment Panel III criteria for Americans [28].
Omega-3 PUFA levels were detected using electron capture negative-ion mass spectrometry. Total cholesterol levels were measured using the enzymatic method, which is a single-reagent, endpoint reaction specific for cholesterol.
We have collated the above confounding variables and their detailed definitions into Table S1.

Process of extracting data

First we searched the NHANES database for oleic acid data and PHQ-9 questionnaire data. We found that this information was collected in the 2011–2014 surveys. Next, covariate information was retrieved for participants in the 2011–2014 surveys, and the download websites for the covariates were identified. We downloaded the required data files locally and combined the data according to the unique identification number assigned to each participant by NHANES. Then, we arrange and clean the combined data to obtain the final dataset to be analysed.

Statistical analyses

Participant characteristics are expressed as means (95% CIs) for continuous variables and as proportions and percentages of the total for categorical variables. Continuous data were compared using one-way analysis of variance, and categorical data were compared using the chi-squared test. Restricted cubic spline (RCS) analysis with 5 knots (5th, 28th, 50th, 73th, and 95th percentiles) was used to characterize the shape of the association between oleic acid levels and depression. Multivariable logistic regression analysis was performed to quantify the association between oleic acid levels and depression. We used three levels of adjustment: Model 1 was adjusted for age, sex, and race/ethnicity; Model 2 was further adjusted for education level, marital status, physical activity, BMI, smoking status, and alcohol status; and Model 3 was additionally adjusted for MetS, omega-3 PUFAs, and total cholesterol. We also performed a sensitivity analysis to ensure that the results were robust. Oleic acid was converted into a categorical variable (quartiles), and the p-value for trend was calculated. This method provides a more visual representation of the changes of depression with increasing oleic acid levels [2932].
In total, 456 (10.2%) participants were excluded from the analyses because of missing values in their covariates. These participants were not included in the analyses that adjusted for the corresponding missing covariates. Imputations of missing data were conducted for sensitivity analyses using the missForest R package, which is a random forest-based technique that is highly computationally efficient for high-dimensional data consisting of both categorical and continuous predictors [33]. Subgroup analyses were performed using stratified multivariable logistic regression analyses.
All statistical analyses in this study were conducted in accordance with CDC guidelines. All analyses were performed using R (The R Foundation, Vienna, Austria) and Empower (X & Y Solutions, Boston, MA). A two-sided p-value < 0.05 was considered statistically significant.

Results

Participant characteristics

In total, 4,459 participants were included for statistical analysis (Fig. S1). Table 1 shows the characteristics of participants according to quartiles of serum oleic acid levels (Q1, ≤ 1.54 mmol/L; Q2, > 1.54 mmol/L to 1.94 mmol/L; Q3, > 1.94 mmol/L to < 2.51 mmol/L; Q4, ≥ 2.51 mmol/L). Participants with the highest oleic acid level (Q4; ≥ 2.51 mmol/L) were more likely to be older, non-Hispanic White, married or living with the partner, and a current or former smoker; have lower physical activity; have higher BMI values, omega-3 PUFA levels, and total cholesterol levels; and were more likely to have MetS and depression than participants in the other groups (all p-value < 0.05).
Table 1
Characteristics of study participants aged ≥ 18 years from the 2011–2014 National Health and Nutrition Examination Survey by oleic acid level (n = 4,459)
Characteristic
Overall
Oleic acid (18:1n-9) quartiles, mmol/L
p-value
Q1
Q2
Q3
Q4
(≤ 1.54 mmol/L)
(> 1.54 to 1.94 mmol/L)
(> 1.94 to < 2.51 mmol/L)
(≥ 2.51 mmol/L)
Oleic acid level, mmol/L, mean (95% CI)
2.21 (2.14, 2.29)
1.29 (1.27, 1.31)
1.74 (1.73, 1.75)
2.19 (2.18, 2.20)
3.49 (3.35, 3.63)
 
Sample size, n (%)
4459 (100)
1136 (25.48)
1105 (24.78)
1103 (24.74)
1115 (25.01)
 
Male, n (%)
2207 (49.5)
518 (46.84)
532 (47.39)
547 (47.33)
610 (55.37)
0.013
Age, years, mean (95% CI)
46.53 (45.59, 47.47)
39.05 (37.51, 40.60)
46.30 (44.66, 47.95)
48.82 (47.43, 50.21)
51.14 (49.92, 52.37)
 < 0.001
Educational level, n (%)
0.409
 < High school
1015 (22.77)
236 (16.24)
241 (17.02)
265 (18.45)
273 (16.98)
 
 Completed high school
964 (21.63)
264 (23.21)
239 (20.28)
223 (17.85)
238 (21.26)
 
 > High school
2478 (55.6)
636 (60.56)
624 (62.70)
615 (63.71)
603 (61.76)
 
Race/ethnicity, n (%)
 < 0.001
 Non-Hispanic White
1880 (42.16)
364 (55.28)
471 (68.66)
494 (71.10)
551 (73.19)
 
 Non-Hispanic Black
948 (21.26)
394 (21.48)
256 (12.38)
178 (7.52)
120 (5.28)
 
 Mexican American
539 (12.09)
105 (8.25)
116 (7.08)
166 (9.21)
152 (8.43)
 
 Other Hispanic
436 (9.78)
103 (6.55)
96 (5.00)
118 (6.26)
119 (5.73)
 
 Other race/multiple races
656 (14.71)
170 (8.44)
166 (6.88)
147 (5.92)
173 (7.36)
 
Marital status, n (%)
0.044
 Married/Living with partner
2497 (59.3)
524 (57.22)
649 (65.02)
651 (65.88)
673 (64.00)
 
 Widowed/Divorced/Separated/Never married
1714 (40.7)
477 (42.78)
405 (34.98)
413 (34.12)
419 (36.00)
 
 Alcohol status, n (%)
3197 (71.79)
809 (76.44)
775 (76.05)
787 (78.27)
826 (80.42)
0.162
Smoking status, n (%)
 < 0.001
 Never smoking
2501 (57.64)
693 (63.70)
646 (59.54)
613 (56.48)
549 (49.83)
 
 Former smoker
1000 (23.05)
211 (19.47)
252 (24.16)
249 (24.09)
288 (26.57)
 
 Current smoker
838 (19.31)
176 (16.83)
179 (16.30)
218 (19.43)
265 (23.59)
 
Physical activity, n (%)
 < 0.001
 Inactive
2178 (48.85)
492 (42.43)
532 (45.18)
545 (46.12)
609 (52.50)
 
 Moderate
1224 (27.45)
270 (22.43)
321 (30.42)
323 (30.06)
310 (29.68)
 
 Vigorous
400 (8.97)
154 (13.56)
89 (8.36)
86 (7.46)
71 (6.29)
 
 Both moderate and vigorous
657 (14.73)
220 (21.57)
163 (16.05)
149 (16.35)
125 (11.52)
 
BMI, n (%)
 < 0.001
 < 25.0 kg/m2
1391 (31.48)
460 (41.76)
382 (34.50)
320 (29.68)
229 (17.89)
 
 25.0 to < 30.0 kg/m2
1423 (32.21)
342 (31.67)
356 (33.46)
355 (33.52)
370 (33.46)
 
 ≥ 30.0 kg/m2
1604 (36.31)
330 (26.56)
356 (32.04)
418 (36.80)
500 (48.65)
 
 Total cholesterol, mmol/L, mean (95% CI)
4.93 (4.88, 4.97)
4.27 (4.20, 4.34)
4.69 (4.64, 4.75)
5.13 (5.05, 5.21)
5.53 (5.45, 5.61)
 < 0.001
 Omega-3 PUFAs, μmol/L, mean (95% CI)
363.63 (353.97, 373.29)
269.95 (259.92, 279.98)
320.08 (305.85, 334.31)
366.08 (353.66, 378.50)
485.11 (473.09, 497.13)
 < 0.001
 Metabolic Syndrome, n (%)
1463 (33.09)
173 (12.81)
245 (20.95)
348 (28.39)
697 (65.04)
 < 0.001
 Depression, n (%)
383 (8.59)
66 (5.69)
87 (6.87)
94 (7.23)
136 (11.19)
0.002
Abbreviations: NHANES National Health and Nutrition Examination Survey, Q Quantile, BMI Body mass index, PUFAs Polyunsaturated fatty acids
A comparison of characteristics between participants included and excluded (excluded for the absence of oleic acid level data or incomplete PHQ-9) from the analysis is shown in Table S1 in the Supplementary Material. Missing data are listed in Table S2. To avoid the effect of outliers on the results, we excluded outlier patients (1.05%) from subsequent analysis. Owing to the skewed distribution of serum oleic acid levels, outliers were identified using the Huber method [34].

Association of oleic acid level and depression

According to RCS, oleic acid levels were positively associated with depression (Fig. 1). Using multivariable logistic regression analysis, Table 2 quantifies the relationship between oleic acid levels and depression. Oleic acid was positively linked with depression in the crude model (OR = 1.35, 95% confidence interval [CI]: 1.16–1.57, p = 0.003). A significant correlation between oleic acid levels and depression was still detected in models after accounting for various variables (model 1: OR = 1.40, 95% CI: 1.21–1.61; model 2: OR = 1.29, 95% CI: 1.10–1.50; model 3: OR = 1.40, 95% CI: 1.03–1.90).
Table 2
Associations of serum oleic acid with depression (n = 4,382)
 
Crude model
Model 1a
Model 2b
Model 3c
OR (95% CI)
p-value
OR (95% CI)
p-value
OR (95% CI)
p-value
OR (95% CI)
p-value
Per 1 mmol/L increase
1.35 (1.16, 1.57)
0.003
1.40 (1.21, 1.61)
 < 0.001
1.29 (1.10, 1.50)
0.003
1.40 (1.03, 1.90)
0.034
Quartiles
 Q1 (≤ 1.53 mmol/L)
Reference (1)
 
Reference (1)
 
Reference (1)
 
Reference (1)
 
 Q2 (> 1.53 to 1.93 mmol/L)
1.22 (0.82, 1.82)
0.319
1.25 (0.82, 1.90)
0.262
1.31 (0.83, 2.06)
0.216
1.37 (0.82, 2.28)
0.197
 Q3 (> 1.93 to < 2.47 mmol/L)
1.30 (0.93, 1.83)
0.124
1.33 (0.91, 1.95)
0.135
1.37 (0.86, 2.21)
0.169
1.51 (0.86, 2.67)
0.122
 Q4 (≥ 2.47 mmol/L)
2.03 (1.38, 3.00)
 < 0.001
2.21 (1.60, 3.23)
 < 0.001
1.93 (1.23, 3.04)
0.008
2.22 (1.04, 4.73)
0.017
p for trend
 < 0.001
 
 < 0.001
 
0.009
 
0.043
 
Abbreviations: CI Confidence interval, OR Odds ratio, Q Quantile
In multivariate regression, samples with missing values for covariates in the model were removed
aCrude Model: Unadjusted (n = 4,382)
bModel 1: Adjust for age, sex, and race/ethnicity (n = 4,382)
cModel 2: Adjust for the variables in Model 1 plus education level, marital status, physical activity, body mass index, smoking status, and alcohol status (n = 4,093)
dModel 3: Adjust for the variables in Model 2 plus metabolic syndrome, omega-3 polyunsaturated fatty acids, and total cholesterol (n = 3,928)
We also converted oleic acid from a continuous variable to a categorical variable (quartiles). In the fully adjusted Model 3, compared with participants in the first oleic acid quartile, participants in the fourth quartile were associated with an increased prevalence of depression (OR = 2.22, 95% CI: 1.04–4.73). Moreover, the p value for trend was significant in all models. We also performed sensitivity analyses using datasets containing outliers, and the results were stable (Table S4).
Sensitivity analyses using the five data sets generated by multiple imputations for missing covariates yielded results consistent with those of the primary analysis (Table S5). All covariable subgroup analyses revealed a pattern similar to the main analysis pattern (all p for interaction > 0.05) (Table S6).
According to a recent study, a PHQ-9 cutoff score of 10 may overestimate the prevalence of depression [35]. Moreover, a systematic review reports that the overall sensitivity (0.37–0.98) and selectivity (0.42–0.99) of PHQ-9 to be ranged widely in primary care samples [36]. Therefore, we also examined the correlation between serum oleic acid levels and PHQ-9 scores as a sensitivity analysis. Because of the approximate gamma distribution of the PHQ-9 score, the association of oleic acid with the PHQ-9 score was tested by generalized linear models (log-link function and a gamma distribution). Because the outcome variable could not include 0 in the model, an increase of 0.1 in the original PHQ-9 score was used as the outcome variable (0.1–27.1). We also analyzed the association between oleic acid levels and PHQ-9 score using linear regression. Analyses of the PHQ-9 score as a continuous variable were performed as follows. We found that serum oleic acid levels were positively correlated with PHQ-9 score (Table S7).

Discussion

We examined the association between serum oleic acid levels and depression in this population-based cross-sectional study. Higher serum oleic acid levels were associated with a higher prevalence of depression in the included American population after adjusting for potential confounders.
Previous studies have examined the association between oleic acid levels and MDD but have yielded inconsistent results. In a study of 134 participants aged 6–18 years by Zhou et al., plasma oleic acid levels were lower in both 52 first-episode drug-naive patients with MDD and 32 drug-treated patients with MDD than in the healthy controls [8]. Ding et al. collected plasma samples from 25 healthy controls and 46 patients with MDD, including 23 patients with previous early life stress and 23 patients without early life stress, and found a decrease in oleic acid in patients with MDD than in the healthy controls [9]. McNamara et al. studied the FA composition of the cadaveric superior temporal gyrus and found no significant differences in oleic acid levels between patients with MDD and healthy controls [10].
However, in a case–control study of 137 patients with recurrent MDD and 65 matched non-depressive controls, plasma oleic acid levels were significantly higher in patients with recurrent MDD than in the healthy controls [11]. Using a genetic instrumental variable design, Zeng et al. found oleic acid to be associated with depression risk [37]. These studies showed inconsistent results, which may be due to the sample sizes and different study populations. Studies that used small sample sizes and did not control for confounding factors found reduced or unchanged oleic acid levels in patients with MDD. Our research on the relationship between oleic acid levels and depression used a sample pool of adults with marked racial/ethnic diversity from NHANES. To the best of our knowledge, this observational study used the largest sample size to examine the association between oleic acid levels and depression.
This study adjusted for confounding variables in the analysis of the relationship between serum oleic acid levels and depression. Confounding variables were selected for this study based on previous literature [11, 27]. Age, sex, and race/ethnicity were chosen as covariates because they are basic demographic information and have been shown to be associated with lipid metabolism and depression [38]. Education level and marital status were chosen as covariates because they are sociological factors that are commonly adjusted for when exploring the relationship between depression and lipid metabolism [3941]. These variables can influence an individual's lifestyle, social support, and access to healthcare resources, which could affect the depressive conditions. Body mass index, smoking status, alcohol status, and physical activity were included because lifestyle habits and health status are known to impact both lipid levels and depression. Metabolic syndrome, omega-3 polyunsaturated fatty acids, and total cholesterol all reflect lipid metabolism and have all been shown to be associated with depression [4244]. Adjusting for these confounding factors can provide a better understanding of the relationship between serum oleic acid levels and depression.
Several mechanisms may underlie the relationship between oleic acid levels and depression. Oleic acid can reduce the expression of neuropeptide Y in the hypothalamus [45], which has an antidepressant-like effects and plays a major role in stress responses and resilience. In human neural cells, excess oleic acid could cause α-synuclein inclusion formation, resulting in neurotoxicity [46]. Locally increased oleic acid levels at the ependymal surface of the brain could result in the inhibition of neural stem cell proliferation and the deterioration of neurogenic niches [47]. Additionally, oleic acid promotes lipid accumulation and induces an inflammatory phagocyte phenotype [14]. In summary, the mechanisms underlying the oleic acid-depression relationship may be related to neuroinflammation, neurotransmitter disorders, and nerve cell damage. These are the possible mechanisms, as a cross-sectional analysis based on the NHANES database, we were unable to validate the above mechanisms. We will explore the mechanisms underlying the oleic acid-depression relationship in future studies (e.g., exploring the role that resilience plays).
A clearer understanding of the role of oleic acid in depression may lead to new preventive and therapeutic methods. The blood oleic acid concentration reflects the mixed effects of endogenous processing and recent consumption [48]. The endogenous synthesis of oleic acid depends on a rate-limiting step catalyzed by stearoyl-CoA desaturase (SCD), and the concentration of oleic acid could be reduced by SCD inhibitors [7]. Studies have shown that SCD inhibitors play a beneficial role by reducing the oleic acid concentration in animal models of Parkinson's disease [46], Alzheimer's disease [47], and demyelinating disorders [14]. Additionally, oleic acid intake is positively associated with symptoms of anxiety and depression in women [12, 13]. A high-fat diet can increase oleic acid levels and promote depression-like behavior in mice, and the serum oleic acid level in mice significantly correlates with depressive-like behavior [49]. It is necessary to further investigate the potential significance of changing circulating oleic acid levels in depression.
Our study had a few limitations. Owing to the cross-sectional study design of the NHANES, no causal links between serum oleic acid and depression could be established. Second, our community population was not a population of patients with clinically diagnosed MDD, highlighting the need for similar large studies of patients with MDD in the future to fully generalize our findings to these patients.

Conclusion

Our research, using a cohort of adults with marked racial/ethnic diversity from the NHANES, suggested a positive association between serum oleic acid levels and depression. A better understanding of the role of oleic acid in depression may lead to new preventive and therapeutic methods. Thus, carefully designed prospective studies are necessary to explore the positive effects of changing serum oleic acid levels through diet, medicine, or other measures on depression.

Acknowledgements

Not applicable.

Declarations

The National Center for Health Statistics Research Ethics Review Board authorized the NHANES study protocols in compliance with the revised Declaration of Helsinki. All participants provided informed consent.
Not applicable.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
2.
Zurück zum Zitat Chang J-J, Ji Y, Li Y-H, Pan H-F, Su P-Y. Prevalence of anxiety symptom and depressive symptom among college students during COVID-19 pandemic: A meta-analysis. J Affect Disord. 2021;292:242–54.PubMedPubMedCentralCrossRef Chang J-J, Ji Y, Li Y-H, Pan H-F, Su P-Y. Prevalence of anxiety symptom and depressive symptom among college students during COVID-19 pandemic: A meta-analysis. J Affect Disord. 2021;292:242–54.PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Daly M, Sutin AR, Robinson E. Depression reported by US adults in 2017–2018 and March and April 2020. J Affect Disord. 2021;278:131–5.PubMedCrossRef Daly M, Sutin AR, Robinson E. Depression reported by US adults in 2017–2018 and March and April 2020. J Affect Disord. 2021;278:131–5.PubMedCrossRef
4.
Zurück zum Zitat Baumgart P, Garrick T. Assessment of Depressive Symptoms in Medically Ill Patients. JAMA. 2021;325:2497–8.PubMedCrossRef Baumgart P, Garrick T. Assessment of Depressive Symptoms in Medically Ill Patients. JAMA. 2021;325:2497–8.PubMedCrossRef
5.
Zurück zum Zitat Calder PC. Functional Roles of Fatty Acids and Their Effects on Human Health. J Parenter Enter Nutr. 2015;39(1_suppl):18S-32S. Calder PC. Functional Roles of Fatty Acids and Their Effects on Human Health. J Parenter Enter Nutr. 2015;39(1_suppl):18S-32S.
6.
Zurück zum Zitat Bazinet RP, Layé S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat Rev Neurosci. 2014;15:771–85.PubMedCrossRef Bazinet RP, Layé S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat Rev Neurosci. 2014;15:771–85.PubMedCrossRef
7.
Zurück zum Zitat Staiger H, Staiger K, Stefan N, Wahl HG, Machicao F, Kellerer M, et al. Palmitate-Induced Interleukin-6 Expression in Human Coronary Artery Endothelial Cells. Diabetes. 2004;53:3209–16.PubMedCrossRef Staiger H, Staiger K, Stefan N, Wahl HG, Machicao F, Kellerer M, et al. Palmitate-Induced Interleukin-6 Expression in Human Coronary Artery Endothelial Cells. Diabetes. 2004;53:3209–16.PubMedCrossRef
8.
Zurück zum Zitat Zhou X, Liu L, Lan X, Cohen D, Zhang Y, Ravindran AV, et al. Polyunsaturated fatty acids metabolism, purine metabolism and inosine as potential independent diagnostic biomarkers for major depressive disorder in children and adolescents. Mol Psychiatry. 2019;24:1478–88.PubMedCrossRef Zhou X, Liu L, Lan X, Cohen D, Zhang Y, Ravindran AV, et al. Polyunsaturated fatty acids metabolism, purine metabolism and inosine as potential independent diagnostic biomarkers for major depressive disorder in children and adolescents. Mol Psychiatry. 2019;24:1478–88.PubMedCrossRef
9.
Zurück zum Zitat Ding X, Yang S, Li W, Liu Y, Li Z, Zhang Y, et al. The potential biomarker panels for identification of Major Depressive Disorder (MDD) patients with and without early life stress (ELS) by metabonomic analysis. PLoS ONE. 2014;9:e97479.PubMedPubMedCentralCrossRef Ding X, Yang S, Li W, Liu Y, Li Z, Zhang Y, et al. The potential biomarker panels for identification of Major Depressive Disorder (MDD) patients with and without early life stress (ELS) by metabonomic analysis. PLoS ONE. 2014;9:e97479.PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat McNamara RK, Rider T, Jandacek R, Tso P. Abnormal fatty acid pattern in the superior temporal gyrus distinguishes bipolar disorder from major depression and schizophrenia and resembles multiple sclerosis. Psychiatry Res. 2014;215:560–7.PubMedPubMedCentralCrossRef McNamara RK, Rider T, Jandacek R, Tso P. Abnormal fatty acid pattern in the superior temporal gyrus distinguishes bipolar disorder from major depression and schizophrenia and resembles multiple sclerosis. Psychiatry Res. 2014;215:560–7.PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Assies J, Pouwer F, Lok A, Mocking RJT, Bockting CLH, Visser I, et al. Plasma and erythrocyte fatty acid patterns in patients with recurrent depression: a matched case-control study. PLoS ONE. 2010;5:e10635.PubMedPubMedCentralCrossRef Assies J, Pouwer F, Lok A, Mocking RJT, Bockting CLH, Visser I, et al. Plasma and erythrocyte fatty acid patterns in patients with recurrent depression: a matched case-control study. PLoS ONE. 2010;5:e10635.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Daley C, Patterson A, Sibbritt D, MacDonald-Wicks L. Unsaturated fat intakes and mental health outcomes in young women from the Australian Longitudinal Study on Women’s Heath. Public Health Nutr. 2015;18:546–53.PubMedCrossRef Daley C, Patterson A, Sibbritt D, MacDonald-Wicks L. Unsaturated fat intakes and mental health outcomes in young women from the Australian Longitudinal Study on Women’s Heath. Public Health Nutr. 2015;18:546–53.PubMedCrossRef
13.
Zurück zum Zitat Li D, Tong Y, Li Y. Associations between dietary oleic acid and linoleic acid and depressive symptoms in perimenopausal women: The Study of Women’s Health Across the Nation. Nutrition. 2020;71:110602.PubMedCrossRef Li D, Tong Y, Li Y. Associations between dietary oleic acid and linoleic acid and depressive symptoms in perimenopausal women: The Study of Women’s Health Across the Nation. Nutrition. 2020;71:110602.PubMedCrossRef
14.
Zurück zum Zitat Bogie JFJ, Grajchen E, Wouters E, Corrales AG, Dierckx T, Vanherle S, et al. Stearoyl-CoA desaturase-1 impairs the reparative properties of macrophages and microglia in the brain. J Exp Med. 2020;217:e20191660.PubMedPubMedCentralCrossRef Bogie JFJ, Grajchen E, Wouters E, Corrales AG, Dierckx T, Vanherle S, et al. Stearoyl-CoA desaturase-1 impairs the reparative properties of macrophages and microglia in the brain. J Exp Med. 2020;217:e20191660.PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Hamilton LK, Moquin-Beaudry G, Mangahas CL, Pratesi F, Aubin M, Aumont A, et al. Stearoyl-CoA Desaturase inhibition reverses immune, synaptic and cognitive impairments in an Alzheimer’s disease mouse model. Nat Commun. 2022;13:2061.PubMedPubMedCentralCrossRef Hamilton LK, Moquin-Beaudry G, Mangahas CL, Pratesi F, Aubin M, Aumont A, et al. Stearoyl-CoA Desaturase inhibition reverses immune, synaptic and cognitive impairments in an Alzheimer’s disease mouse model. Nat Commun. 2022;13:2061.PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Olsen T, Turner C, Øvrebø B, Bastani NE, Refsum H, Vinknes KJ. Postprandial effects of a meal low in sulfur amino acids and high in polyunsaturated fatty acids compared to a meal high in sulfur amino acids and saturated fatty acids on stearoyl CoA-desaturase indices and plasma sulfur amino acids: a pilot study. BMC Res Notes. 2020;13:379.PubMedPubMedCentralCrossRef Olsen T, Turner C, Øvrebø B, Bastani NE, Refsum H, Vinknes KJ. Postprandial effects of a meal low in sulfur amino acids and high in polyunsaturated fatty acids compared to a meal high in sulfur amino acids and saturated fatty acids on stearoyl CoA-desaturase indices and plasma sulfur amino acids: a pilot study. BMC Res Notes. 2020;13:379.PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Tardiff DF, Lucas M, Wrona I, Chang B, Chung CY, Le Bourdonnec B, et al. Non-clinical Pharmacology of YTX-7739: a Clinical Stage Stearoyl-CoA Desaturase Inhibitor Being Developed for Parkinson’s Disease. Mol Neurobiol. 2022;59:2171–89.PubMedPubMedCentralCrossRef Tardiff DF, Lucas M, Wrona I, Chang B, Chung CY, Le Bourdonnec B, et al. Non-clinical Pharmacology of YTX-7739: a Clinical Stage Stearoyl-CoA Desaturase Inhibitor Being Developed for Parkinson’s Disease. Mol Neurobiol. 2022;59:2171–89.PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Lagerstedt SA, Hinrichs DR, Batt SM, Magera MJ, Rinaldo P, McConnell JP. Quantitative determination of plasma c8–c26 total fatty acids for the biochemical diagnosis of nutritional and metabolic disorders. Mol Genet Metab. 2001;73:38–45.PubMedCrossRef Lagerstedt SA, Hinrichs DR, Batt SM, Magera MJ, Rinaldo P, McConnell JP. Quantitative determination of plasma c8–c26 total fatty acids for the biochemical diagnosis of nutritional and metabolic disorders. Mol Genet Metab. 2001;73:38–45.PubMedCrossRef
23.
Zurück zum Zitat Lamers F, Jonkers CCM, Bosma H, Penninx BWJH, Knottnerus JA, van Eijk JThM. Summed score of the Patient Health Questionnaire-9 was a reliable and valid method for depression screening in chronically ill elderly patients. J Clin Epidemiol. 2008;61:679–87.PubMedCrossRef Lamers F, Jonkers CCM, Bosma H, Penninx BWJH, Knottnerus JA, van Eijk JThM. Summed score of the Patient Health Questionnaire-9 was a reliable and valid method for depression screening in chronically ill elderly patients. J Clin Epidemiol. 2008;61:679–87.PubMedCrossRef
24.
Zurück zum Zitat Thakur VK, Wong JY, Randall JR, Bolton JM, Parikh SV, Mota N, et al. An evaluation of large group cognitive behaviour therapy with mindfulness (CBTm) classes. BMC Psychiatry. 2019;19:132.PubMedPubMedCentralCrossRef Thakur VK, Wong JY, Randall JR, Bolton JM, Parikh SV, Mota N, et al. An evaluation of large group cognitive behaviour therapy with mindfulness (CBTm) classes. BMC Psychiatry. 2019;19:132.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Leavens A, Patten SB, Hudson M, Baron M, Thombs BD, Canadian Scleroderma Research Group. Influence of somatic symptoms on Patient Health Questionnaire-9 depression scores among patients with systemic sclerosis compared to a healthy general population sample. Arthritis Care Res. 2012;64:1195–201. Leavens A, Patten SB, Hudson M, Baron M, Thombs BD, Canadian Scleroderma Research Group. Influence of somatic symptoms on Patient Health Questionnaire-9 depression scores among patients with systemic sclerosis compared to a healthy general population sample. Arthritis Care Res. 2012;64:1195–201.
26.
Zurück zum Zitat Manea L, Gilbody S, McMillan D. Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): a meta-analysis. Can Med Assoc J. 2012;184:E191–6.CrossRef Manea L, Gilbody S, McMillan D. Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): a meta-analysis. Can Med Assoc J. 2012;184:E191–6.CrossRef
27.
Zurück zum Zitat Bot M, Milaneschi Y, Al-Shehri T, Amin N, Garmaeva S, Onderwater GLJ, et al. Metabolomics Profile in Depression: A Pooled Analysis of 230 Metabolic Markers in 5283 Cases With Depression and 10,145 Controls. Biol Psychiatry. 2020;87:409–18.PubMedCrossRef Bot M, Milaneschi Y, Al-Shehri T, Amin N, Garmaeva S, Onderwater GLJ, et al. Metabolomics Profile in Depression: A Pooled Analysis of 230 Metabolic Markers in 5283 Cases With Depression and 10,145 Controls. Biol Psychiatry. 2020;87:409–18.PubMedCrossRef
28.
Zurück zum Zitat Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–52.PubMedCrossRef Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–52.PubMedCrossRef
29.
Zurück zum Zitat He K, Pang T, Huang H. The relationship between depressive symptoms and BMI: 2005–2018 NHANES data. J Affect Disord. 2022;313:151–7.PubMedCrossRef He K, Pang T, Huang H. The relationship between depressive symptoms and BMI: 2005–2018 NHANES data. J Affect Disord. 2022;313:151–7.PubMedCrossRef
30.
Zurück zum Zitat Iranpour S, Sabour S. Inverse association between caffeine intake and depressive symptoms in US adults: data from National Health and Nutrition Examination Survey (NHANES) 2005–2006. Psychiatry Res. 2019;271:732–9.PubMedCrossRef Iranpour S, Sabour S. Inverse association between caffeine intake and depressive symptoms in US adults: data from National Health and Nutrition Examination Survey (NHANES) 2005–2006. Psychiatry Res. 2019;271:732–9.PubMedCrossRef
31.
Zurück zum Zitat Shi Y-Y, Zheng R, Cai J-J, Qian S-Z. The association between triglyceride glucose index and depression: data from NHANES 2005–2018. BMC Psychiatry. 2021;21:267.PubMedPubMedCentralCrossRef Shi Y-Y, Zheng R, Cai J-J, Qian S-Z. The association between triglyceride glucose index and depression: data from NHANES 2005–2018. BMC Psychiatry. 2021;21:267.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Zhao L, Sun Y, Liu Y, Yan Z, Peng W. A J-shaped association between Dietary Inflammatory Index (DII) and depression: A cross-sectional study from NHANES 2007–2018. J Affect Disord. 2023;323:257–63.PubMedCrossRef Zhao L, Sun Y, Liu Y, Yan Z, Peng W. A J-shaped association between Dietary Inflammatory Index (DII) and depression: A cross-sectional study from NHANES 2007–2018. J Affect Disord. 2023;323:257–63.PubMedCrossRef
33.
Zurück zum Zitat Stekhoven DJ, Bühlmann P. MissForest–non-parametric missing value imputation for mixed-type data. Bioinforma Oxf Engl. 2012;28:112–8.CrossRef Stekhoven DJ, Bühlmann P. MissForest–non-parametric missing value imputation for mixed-type data. Bioinforma Oxf Engl. 2012;28:112–8.CrossRef
35.
Zurück zum Zitat Levis B, Benedetti A, Ioannidis JPA, Sun Y, Negeri Z, He C, et al. Patient Health Questionnaire-9 scores do not accurately estimate depression prevalence: individual participant data meta-analysis. J Clin Epidemiol. 2020;122:115-128.e1.PubMedCrossRef Levis B, Benedetti A, Ioannidis JPA, Sun Y, Negeri Z, He C, et al. Patient Health Questionnaire-9 scores do not accurately estimate depression prevalence: individual participant data meta-analysis. J Clin Epidemiol. 2020;122:115-128.e1.PubMedCrossRef
36.
Zurück zum Zitat Costantini L, Pasquarella C, Odone A, Colucci ME, Costanza A, Serafini G, et al. Screening for depression in primary care with Patient Health Questionnaire-9 (PHQ-9): A systematic review. J Affect Disord. 2021;279:473–83.PubMedCrossRef Costantini L, Pasquarella C, Odone A, Colucci ME, Costanza A, Serafini G, et al. Screening for depression in primary care with Patient Health Questionnaire-9 (PHQ-9): A systematic review. J Affect Disord. 2021;279:473–83.PubMedCrossRef
37.
Zurück zum Zitat Zeng L, Lv H, Wang X, Xue R, Zhou C, Liu X, et al. Causal effects of fatty acids on depression: Mendelian randomization study. Front Nutr. 2022;9:1010476.PubMedPubMedCentralCrossRef Zeng L, Lv H, Wang X, Xue R, Zhou C, Liu X, et al. Causal effects of fatty acids on depression: Mendelian randomization study. Front Nutr. 2022;9:1010476.PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Aggarwal R, Bhatt DL, Rodriguez F, Yeh RW, Wadhera RK. Trends in Lipid Concentrations and Lipid Control Among US Adults, 2007–2018. JAMA. 2022;328:737–45.PubMedPubMedCentralCrossRef Aggarwal R, Bhatt DL, Rodriguez F, Yeh RW, Wadhera RK. Trends in Lipid Concentrations and Lipid Control Among US Adults, 2007–2018. JAMA. 2022;328:737–45.PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Rhee SJ, Kim EY, Kim SH, Lee HJ, Kim B, Ha K, et al. Subjective depressive symptoms and metabolic syndrome among the general population. Prog Neuropsychopharmacol Biol Psychiatry. 2014;54:223–30.PubMedCrossRef Rhee SJ, Kim EY, Kim SH, Lee HJ, Kim B, Ha K, et al. Subjective depressive symptoms and metabolic syndrome among the general population. Prog Neuropsychopharmacol Biol Psychiatry. 2014;54:223–30.PubMedCrossRef
40.
Zurück zum Zitat Kim EY, Kim SH, Ha K, Lee HJ, Yoon DH, Ahn YM. Depression trajectories and the association with metabolic adversities among the middle-aged adults. J Affect Disord. 2015;188:14–21.PubMedCrossRef Kim EY, Kim SH, Ha K, Lee HJ, Yoon DH, Ahn YM. Depression trajectories and the association with metabolic adversities among the middle-aged adults. J Affect Disord. 2015;188:14–21.PubMedCrossRef
41.
Zurück zum Zitat Zhang R, Sun J, Li Y, Zhang D. Associations of n-3, n-6 Fatty Acids Intakes and n-6:n-3 Ratio with the Risk of Depressive Symptoms: NHANES 2009–2016. Nutrients. 2020;12. Zhang R, Sun J, Li Y, Zhang D. Associations of n-3, n-6 Fatty Acids Intakes and n-6:n-3 Ratio with the Risk of Depressive Symptoms: NHANES 2009–2016. Nutrients. 2020;12.
42.
Zurück zum Zitat Zhang M, Chen J, Yin Z, Wang L, Peng L. The association between depression and metabolic syndrome and its components: a bidirectional two-sample Mendelian randomization study. Transl Psychiatry. 2021;11:633.PubMedPubMedCentralCrossRef Zhang M, Chen J, Yin Z, Wang L, Peng L. The association between depression and metabolic syndrome and its components: a bidirectional two-sample Mendelian randomization study. Transl Psychiatry. 2021;11:633.PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Zhou L, Xiong J-Y, Chai Y-Q, Huang L, Tang Z-Y, Zhang X-F, et al. Possible antidepressant mechanisms of omega-3 polyunsaturated fatty acids acting on the central nervous system. Front Psychiatry. 2022;13:933704.PubMedPubMedCentralCrossRef Zhou L, Xiong J-Y, Chai Y-Q, Huang L, Tang Z-Y, Zhang X-F, et al. Possible antidepressant mechanisms of omega-3 polyunsaturated fatty acids acting on the central nervous system. Front Psychiatry. 2022;13:933704.PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Wagner CJ, Musenbichler C, Böhm L, Färber K, Fischer A-I, von Nippold F, et al. LDL cholesterol relates to depression, its severity, and the prospective course. Prog Neuropsychopharmacol Biol Psychiatry. 2019;92:405–11.PubMedCrossRef Wagner CJ, Musenbichler C, Böhm L, Färber K, Fischer A-I, von Nippold F, et al. LDL cholesterol relates to depression, its severity, and the prospective course. Prog Neuropsychopharmacol Biol Psychiatry. 2019;92:405–11.PubMedCrossRef
45.
Zurück zum Zitat Obici S, Feng Z, Morgan K, Stein D, Karkanias G, Rossetti L. Central Administration of Oleic Acid Inhibits Glucose Production and Food Intake. Diabetes. 2002;51:271–5.PubMedCrossRef Obici S, Feng Z, Morgan K, Stein D, Karkanias G, Rossetti L. Central Administration of Oleic Acid Inhibits Glucose Production and Food Intake. Diabetes. 2002;51:271–5.PubMedCrossRef
46.
Zurück zum Zitat Fanning S, Haque A, Imberdis T, Baru V, Barrasa MI, Nuber S, et al. Lipidomic Analysis of α-Synuclein Neurotoxicity Identifies Stearoyl CoA Desaturase as a Target for Parkinson Treatment. Mol Cell. 2019;73:1001-1014.e8.PubMedCrossRef Fanning S, Haque A, Imberdis T, Baru V, Barrasa MI, Nuber S, et al. Lipidomic Analysis of α-Synuclein Neurotoxicity Identifies Stearoyl CoA Desaturase as a Target for Parkinson Treatment. Mol Cell. 2019;73:1001-1014.e8.PubMedCrossRef
47.
Zurück zum Zitat Hamilton LK, Dufresne M, Joppé SE, Petryszyn S, Aumont A, Calon F, et al. Aberrant Lipid Metabolism in the Forebrain Niche Suppresses Adult Neural Stem Cell Proliferation in an Animal Model of Alzheimer’s Disease. Cell Stem Cell. 2015;17:397–411.PubMedCrossRef Hamilton LK, Dufresne M, Joppé SE, Petryszyn S, Aumont A, Calon F, et al. Aberrant Lipid Metabolism in the Forebrain Niche Suppresses Adult Neural Stem Cell Proliferation in an Animal Model of Alzheimer’s Disease. Cell Stem Cell. 2015;17:397–411.PubMedCrossRef
48.
Zurück zum Zitat Thiébaut ACM, Rotival M, Gauthier E, Lenoir GM, Boutron-Ruault M-C, Joulin V, et al. Correlation Between Serum Phospholipid Fatty Acids and Dietary Intakes Assessed a Few Years Earlier. Nutr Cancer. 2009;61:500–9.PubMedCrossRef Thiébaut ACM, Rotival M, Gauthier E, Lenoir GM, Boutron-Ruault M-C, Joulin V, et al. Correlation Between Serum Phospholipid Fatty Acids and Dietary Intakes Assessed a Few Years Earlier. Nutr Cancer. 2009;61:500–9.PubMedCrossRef
49.
Zurück zum Zitat Yu H, Qin X, Yu Z, Chen Y, Tang L, Shan W. Effects of high-fat diet on the formation of depressive-like behavior in mice. Food Funct. 2021;12:6416–31.PubMedCrossRef Yu H, Qin X, Yu Z, Chen Y, Tang L, Shan W. Effects of high-fat diet on the formation of depressive-like behavior in mice. Food Funct. 2021;12:6416–31.PubMedCrossRef
Metadaten
Titel
Association of serum oleic acid level with depression in American adults: a cross-sectional study
verfasst von
Jiahui Yin
Siyuan Li
Jinling Li
Rongpeng Gong
Zhixia Jia
Junjun Liu
Zhi Jin
Jiguo Yang
Yuanxiang Liu
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
BMC Psychiatry / Ausgabe 1/2023
Elektronische ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-023-05271-0

Weitere Artikel der Ausgabe 1/2023

BMC Psychiatry 1/2023 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.